Risk factor
Limited trading liquidity
Profitability factor
Undervalued vs peers
About
Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women; in vitro diagnostics, acute medical care products, and curative medicines; and information regarding pharmaceuticals...
Company Valuation
Based on key historical and expected multiples, the stock is undervalued relative to its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBITD.
Target Price
The average target price of 4554.T is 2017 and suggests 7% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to de
Buy
Sell